Prolonged hypogonadism after pulsed gonadotropin-releasing hormone agonist for prostate cancer.
Stevens
M J
MJ
Bell
D R
DR
Blome
S A
SA
Begbie
S D
SD
D003131:Combined Modality Therapy; D007172:Erectile Dysfunction / Q000139:chemically induced; D005485:Flutamide / Q000008:administration & dosage; D005640:Follicle Stimulating Hormone / Q000097:blood; D017273:Goserelin / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D013737:Testis / Q000187:drug effects*; D013739:Testosterone / Q000097:blood
D017273:Goserelin; D013739:Testosterone; D005485:Flutamide; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone